Cross-cultural adaptation and content validation of START
Keywords:
Elderly, Pharmaceutical preparations, Drug prescriptions, Health of the elderly, Drug utilization, TranslationsAbstract
CONTEXT AND OBJECTIVE: Non-treatment of diseases or clinical conditions has been considered to con- stitute omission of care in several countries. The aim of the present study was to develop a transcultural adaptation of the Screening Tool to Alert Doctors to the Right Treatment (START) to Brazilian Portuguese and to validate the tool’s content. DESIGN AND SETTING: Cultural adaptation and validation of the START criteria using the Delphi consen- sus technique. METHOD: START was translated from its original language into Brazilian Portuguese, followed by back- translation and validation by means of the modified Delphi technique. For this, an electronic form was de- veloped and sent to 20 experts, who were asked to use a Likert scale to assess the statements included in START, in relation to their pertinence to Brazilian realities. All of the statements that exhibited mean scores greater than 4.0 were considered to have attained consensus. The experts’ identities were kept confidential throughout the validation process. RESULTS: In the first phase of the validation process, 63.6% (14/22) of the statements in START attained consensus. The remaining statements were returned to the experts so that they could have the opportu- nity to review their comments and statements and to assess them again, based on the Likert scale used earlier. In this phase, 100% of the START instrument attained consensus. CONCLUSION: The content of START was entirely validated for Brazil, with all of the original criteria maintained.
Downloads
References
Silva AL, Ribeiro AQ, Klein CH, Acurcio F de A. Utilização de medicamentos por idosos brasileiros, de acordo com a faixa etária: um inquérito postal [Use of medications by elderly Brazilians according to age: a postal survey]. Cad Saude Publica. 2012;28(6):1033-45.
Oliveira MG, Amorim WW, de Jesus SR, Rodrigues VA, Passos LC. Factors associated with potentially inappropriate medication use by the elderly in the Brazilian primary care setting. Int J Clin Pharm. 2012;34(4):626-32.
Barry PJ, Gallagher P, Ryan C, O’Mahony D. START (screening tool to alert doctors to the right treatment) -- an evidence-based screening tool to detect prescribing omissions in elderly patients. Age Ageing. 2007;36(6):632-8.
Page RL 2nd, Ruscin JM. The risk of adverse drug events and hospital- related morbidity and mortality among older adults with potentially inappropriate medication use. Am J Geriatr Pharmacother. 2006;4(4):297-305.
Gallagher P, O’Mahony D. STOPP (Screening Tool of Older Persons’ potentially inappropriate Prescriptions): application to acutely ill elderly patients and comparison with Beers’criteria. Age Ageing. 2008;37(6):673-9.
Diamond IR, Grant RC, Feldman BM, et al. Defining consensus: a systematic review recommends methodologic criteria for reporting of Delphi studies. J Clin Epidemiol. 2014;67(4):401-9.
O’Mahony D, Gallagher P, Ryan C, et al. STOPP & START criteria: A new approach to detecting potentially inappropriate prescribing in old age. European Geriatric Medicine. 2010;1(1):45-51. Available from: http://www.sciencedirect.com/science/article/pii/ S1878764910000112. Accessed in 2015 (Feb 24).
Guillemin F, Bombardier C, Beaton D. Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J Clin Epidemiol. 1993;46(12):1417-32.
Noblat L, Oliveira MG, Santos-Jesus R, Noblat AC, Badaró R. Validation of criteria for nosocomial use of amikacin in Brazil with the Delphi technique. Braz J Infect Dis. 2006;10(3):173-8.
Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009;361(12):1139-51.
Granger CB, Alexander JH, McMurray JJ, et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011;365(11):981-92.
Patel MR, Mahaffey KW, Garg J, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011;365(10):883-91.
Pinto VF. Estudos clínicos de não-inferioridade: fundamentos e controvérsias [Non-inferiority clinical trials: concepts and issues]. J Vasc Bras. 2010;9(3):145-51.
Schwartz GG, Olsson AG, Ezekowitz MD, et al. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA. 2001;285(13):1711-8.
Vale N, Nordmann AJ, Schwartz GG, et al. Statins for acute coronary syndrome. Cochrane Database Syst Rev. 2011;(6):CD006870.
Lobos Bejarano JM, Galve E, Royo-Bordonada MA, et al. Spanish Interdisciplinary Committee for Cardiovascular Disease Prevention and the Spanish Society of Cardiology position statement on dyslipidemia management. Differences between the European and American guidelines. Rev Esp Cardiol (Engl Ed). 2014;67(11):913-9.
Murphy SA, Cannon CP, Wiviott SD, McCabe CH, Braunwald E. Reduction in recurrent cardiovascular events with intensive lipid- lowering statin therapy compared with moderate lipid-lowering statin therapy after acute coronary syndromes from the PROVE IT- TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy- Thrombolysis In Myocardial Infarction 22) trial. J Am Coll Cardiol. 2009;54(25):2358-62.
Kanis JA, McCloskey EV, Johansson H, et al. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int. 2013;24(1):23-57.
Kaufman JM, Reginster JY, Boonen S, et al. Treatment of osteoporosis in men. Bone. 2013;53(1):134-44.
Reid IR. Osteoporosis treatment: focus on safety. Eur J Intern Med. 2013;24(8):691-7.
Lee DS, Markwardt S, McAvay GJ, et al. Effect of β-blockers on cardiac and pulmonary events and death in older adults with cardiovascular disease and chronic obstructive pulmonary disease. Med Care. 2014;52 Suppl 3:S45-51.
Ünlü C, Daniels L, Vrouenraets BC, Boermeester MA. A systematic review of high-fibre dietary therapy in diverticular disease. Int J Colorectal Dis. 2012;27(4):419-27.
Weizman AV, Nguyen GC. Diverticular disease: epidemiology and management. Can J Gastroenterol. 2011;25(7):385-9.
Chang CB, Chan DC. Comparison of published explicit criteria for potentially inappropriate medications in older adults. Drugs Aging. 2010;27(12):947-57.
